Updated 1/16/2019. Linked to available ACC abstracts, added Roth Conference in March 2019 (on schedule) and added EAS in May 2019 as a potential event.

Based on attendance or presentation at prior events, here is a list of potential events (mostly science meetings, some investor conferences) for Resverlogix in the year of the big news. There is no guarantee that Resverlogix will present at all of the events listed below. Did I miss any? If so, let me know!

Biotech Showcase January 7-9, 2019; San Francisco, CA (already presented, see here)

BIO CEO & Investor Conference February 11-12, 2019; New York, NY (Resverlogix and Zenith on schedule, see here)

American College Cardiology (ACC) March 16-18, 2019; New Orleans, LA (on schedule, see abstracts here). Late Breaking Clinical Trial presentations announced by end of January.

Roth Conference March 17-19, 2019; Orange County, CA (on schedule, see here and here)

BIO-Europe Spring March 25-27, 2019; Vienna, Austria

Vascular Discovery: From Genes to Medicine (Formerly ATVB:PVD): May 14-16, 2019; Boston, MA

European Atherosclerosis Society (EAS) May 26-29, 2019; Maastricht, Netherlands

European Renal Association – European Dialysis and Transplant Association (ERA-EDTA): June 13-16, 2019; Budapest, Hungary

BIO-International June 3-6, 2019; Philadelphia, PA

American Diabetes Association (ADA) June 7-11, 2019; San Francisco, CA

Alzheimer's Association International Conference (AAIC) July 14-18, 2019; Los Angeles, CA

European Society of Cardiology (ESC) August 31 to Sept 4, 2019; Paris, France

Clinical Trials on Alzheimer's Disease/Asia  (CTAD Asia) September 13-14, 2019; Beijing, China

European Association for the Study of Diabetes (EASD): Sept 16-20, 2019; Barcelona, Spain

American Society for Nephrology (ASN) Kidney Week Nov 5-10, 2019; Washington, D.C.

BIO-Europe Nov 11-13, 2019

American Heart Association (AHA) November 16-18, 2019; Philadelphia, PA

Clinical Trials on Alzheimer's Disease (CTAD) December 4-7, 2019; San Diego, CA